The total pharmaceutical market in Finland experienced a steady growth trajectory from 2013 to 2023, with some fluctuations noted. In 2023, the market stood at 49 units in volume. The year-on-year variation over the last two years showed a +2.08% increase in 2023 despite a slight -2.04% dip in 2022. Over the last five years, the market demonstrated an average annual growth rate (CAGR) of 2.18%.

Future projections from 2024 to 2028 suggest a continued but slower growth, with an expected CAGR of 1.55% and an overall forecast growth rate of 8% for this period. Such trends indicate a sustained if moderate expansion, which stakeholders should monitor closely.

Future trends to watch for:

Potential impacts of healthcare policy changes and regulation adaptations to the pharmaceutical sector.
Technological advancements in drug development and their influence on market growth.
Global supply chain issues and their implications on Finland’s pharmaceutical imports and exports.
Shifts in patient demand and demographic changes impacting pharmaceutical needs.